EVONETIX

In News

Gene-length DNA synthesis for scaling engineering biology - BioTechniques

BioTechniques - Nov 03, 2023

Evonetix Closes $24 Million USD (£20 Million) Financing - Business Wire

Business Wire - Feb 07, 2023

Back to the future as Diston takes CEO role in Evonetix rebuild - Business Weekly

Business Weekly - Mar 12, 2024

Evonetix closes $24M financing - Labiotech.eu

Labiotech.eu - Feb 07, 2023

Evonetix expands facilities and relocates to central Cambridge, UK - SynBioBeta

SynBioBeta - Oct 30, 2019

Evonetix and Analog Devices Collaborate on Third-Generation DNA Synthesis Platform - Lab Manager

Lab Manager - May 31, 2023

Evonetix Appoints Colin McCracken as Chief Executive Officer - Technology Networks

Technology Networks - Jun 13, 2022

Evonetix Places First DNA Synthesis Development Platform at Imperial College London - Business Wire

Business Wire - Oct 04, 2023

Bringing semiconductor tech to DNA synthesis, Evonetix secures £20 million - Tech.eu

Tech.eu - Feb 07, 2023

Researchers invited to apply for DNA synthesized by Evonetix’s platform - Labiotech.eu

Labiotech.eu - Aug 18, 2022

Stunning: Evonetix’s first chip-synthesised DNA created for the University of Cambridge - Cambridge Independent

Cambridge Independent - May 19, 2023

Synthetic DNA in Drug Discovery and Development - Genetic Engineering and Biotechnology News

Genetic Engineering and Biotechnology News - Sep 01, 2021

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment